- Home
- MQ vs SRRK Comparison
MQ vs SRRK Comparison
Compare MQ & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- SRRK
- Stock Information
- Founded
- MQ 2010
- SRRK 2012
- Country
- MQ United States
- SRRK United States
- Employees
- MQ N/A
- SRRK N/A
- Industry
- MQ Computer Software: Prepackaged Software
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MQ Technology
- SRRK Health Care
- Exchange
- MQ Nasdaq
- SRRK Nasdaq
- Market Cap
- MQ 2.7B
- SRRK 3.0B
- IPO Year
- MQ 2021
- SRRK 2018
- Fundamental
- Price
- MQ $4.53
- SRRK $29.50
- Analyst Decision
- MQ Hold
- SRRK Strong Buy
- Analyst Count
- MQ 13
- SRRK 9
- Target Price
- MQ $5.58
- SRRK $47.88
- AVG Volume (30 Days)
- MQ 4.1M
- SRRK 3.2M
- Earning Date
- MQ 11-05-2025
- SRRK 11-14-2025
- Dividend Yield
- MQ N/A
- SRRK N/A
- EPS Growth
- MQ N/A
- SRRK N/A
- EPS
- MQ N/A
- SRRK N/A
- Revenue
- MQ $553,223,000.00
- SRRK N/A
- Revenue This Year
- MQ $21.19
- SRRK N/A
- Revenue Next Year
- MQ $20.49
- SRRK $1,911.27
- P/E Ratio
- MQ N/A
- SRRK N/A
- Revenue Growth
- MQ 17.47
- SRRK N/A
- 52 Week Low
- MQ $3.37
- SRRK $22.71
- 52 Week High
- MQ $7.04
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- MQ 30.01
- SRRK 41.33
- Support Level
- MQ $4.53
- SRRK $28.82
- Resistance Level
- MQ $4.90
- SRRK $31.85
- Average True Range (ATR)
- MQ 0.17
- SRRK 1.87
- MACD
- MQ 0.02
- SRRK -0.24
- Stochastic Oscillator
- MQ 8.14
- SRRK 24.14
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.